Loading...
XNAS
QSI
Market cap187mUSD
Jul 09, Last price  
0.96USD
1D
5.45%
1Q
29.97%
IPO
-90.28%
Name

Quantum-Si Inc

Chart & Performance

D1W1MN
XNAS:QSI chart
P/E
P/S
78.15
EPS
Div Yield, %
Shrs. gr., 5y
105.64%
Rev. gr., 5y
%
Revenues
2m
-20.34%
00001,082,0003,058,0002,436,000
Net income
-101m
L+0.33%
-35,797,000-36,612,000-94,989,000-132,442,000-95,960,000-101,007,000-101,339,000
CFO
-95m
L+7.88%
-30,708,000-32,573,000-66,813,000-90,560,000-94,036,000-87,795,000-94,717,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Quantum-Si, Inc. is a life sciences company focused on revolutionizing the growing field of proteomics. It engages in the development of a proprietary universal single-molecule detection platform to enable Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins in a massively parallel fashion. Its platform includes platinum NGPS instrument, platinum analysis software, and consumable kits for platinum instrument. The company was founded by Jonathan M. Rothberg on June 24, 2013 and is headquartered in Branford, CT.
IPO date
Sep 04, 2020
Employees
196
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT